188 related articles for article (PubMed ID: 35898616)
1. A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP
Chaiswing L; Yarana C; St Clair W; Tovmasyan A; Batinic-Haberle I; Spasojevic I; St Clair D
Oxid Med Cell Longev; 2022; 2022():9664636. PubMed ID: 35898616
[TBL] [Abstract][Full Text] [Related]
2. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
[TBL] [Abstract][Full Text] [Related]
3. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).
Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z
Redox Biol; 2014; 2():400-10. PubMed ID: 24624330
[TBL] [Abstract][Full Text] [Related]
4. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
[TBL] [Abstract][Full Text] [Related]
5. Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury.
Batinic-Haberle I; Tovmasyan A; Spasojevic I
Antioxid Redox Signal; 2018 Dec; 29(16):1691-1724. PubMed ID: 29926755
[TBL] [Abstract][Full Text] [Related]
6. Manganese porphyrin redox state in endothelial cells: Resonance Raman studies and implications for antioxidant protection towards peroxynitrite.
Carballal S; Valez V; Alvarez-Paggi D; Tovmasyan A; Batinic-Haberle I; Ferrer-Sueta G; Murgida DH; Radi R
Free Radic Biol Med; 2018 Oct; 126():379-392. PubMed ID: 30144631
[
